Article Text
Articles
Two more hypnotics added to the ‘white list’
Abstract
We have long deplored the excessive number of benzodiazepines on the market1 and in 1985 we selected a few worth including in the DHSS ‘White List’.2 Recently two more have been added to this list - lormetazepam and loprazolam - both of which we had found unremarkable when we reviewed them previously.3,4 Do the more recently published data justify their inclusion?